Hope Theory-Based Nursing Intervention After Hip Fracture Surgery

February 3, 2026 updated by: Institute of Orthopaedic Surgery, Taizhou No.3 People's Hospital

Effect of a Snyder Hope Theory-Based Nursing Intervention on Psychological Status, Pain, and Functional Recovery in Elderly Patients After Hip Fracture Surgery: A Randomized Controlled Trial

This is a randomized controlled trial to evaluate the effectiveness of a Snyder Hope Theory-based nursing intervention on elderly patients following hip fracture surgery. The study aims to improve the patient's psychological well-being, reduce pain, and enhance their functional recovery. Participants will be randomly assigned to either the intervention group or the control group. The intervention involves individualized counseling, goal setting, and rehabilitation training based on the Snyder Hope Theory. The trial will assess changes in hope levels, anxiety, pain, hip joint function, and quality of life before and after the intervention.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

This clinical trial aims to explore the impact of a Snyder Hope Theory-based nursing intervention on elderly patients who have undergone hip fracture surgery. As hip fractures are common among the elderly and often result in prolonged recovery periods, pain, and anxiety, effective interventions are needed to improve recovery outcomes.

In this study, elderly patients over the age of 60, who have undergone hip fracture surgery, will be recruited. They will be randomly assigned to either the intervention group or the control group. The intervention group will receive a specialized nursing care plan incorporating elements of the Snyder Hope Theory, including personalized psychological counseling, rehabilitation goal-setting, and group-based support. The control group will receive standard postoperative care.

The primary outcomes include the improvement in hope levels (measured by the Herth Hope Index), reduction in pain (measured by the Visual Analog Scale), and enhanced physical function (measured by the Harris Hip Score). Secondary outcomes include anxiety reduction and quality of life improvement (measured by the WHOQOL-BREF).

The trial will be conducted over a 2-week period, with assessments before and after the intervention. Data will be analyzed to determine the effectiveness of the intervention in improving psychological, functional, and physical outcomes for elderly patients recovering from hip surgery.

Study Type

Interventional

Enrollment (Estimated)

112

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • China
    • Jiangsu
      • Taizhou, Jiangsu, China, 225300
        • Recruiting
        • Taizhou No. 3 People's Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age ≥ 60 years.
  • Patients with hip fracture requiring surgical intervention.
  • Patients who have undergone hip fracture surgery within the past 2 weeks.
  • Patients who are able to communicate and provide informed consent.
  • Patients and/or their family members who are willing to participate in the study.

Exclusion Criteria:

  • Patients with other lower limb fractures or history of lower limb thrombosis.
  • Patients with multiple fractures.
  • Patients with severe damage to major organs (heart, lungs, brain) or malignant tumors.
  • Patients who have undergone hip replacement surgery in the past.
  • Patients with infectious diseases or immune system disorders.
  • Patients with chronic diseases or neurological disorders.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Snyder Hope Theory-based Nursing Intervention
Participants in the intervention arm will receive a Snyder Hope Theory-based nursing intervention, which includes psychological counseling, goal-setting, rehabilitation training, and peer support to improve hope levels, reduce pain, and enhance functional recovery after hip fracture surgery.
Behavioral: Snyder Hope Theory-based Nursing Intervention
The Snyder Hope Theory-based nursing intervention involves a structured program aimed at improving the psychological well-being and recovery of elderly patients post-hip fracture surgery. The intervention includes psychological counseling, rehabilitation goal-setting, peer support, and motivation enhancement. The nursing intervention is designed to increase hope levels, reduce pain, alleviate anxiety, and improve hip joint function, ultimately enhancing the overall recovery process for the participants.
Active Comparator: Standard Postoperative Care
Participants in the control arm will receive standard postoperative care, including routine pain management, rehabilitation exercises, and general guidance on recovery after hip fracture surgery, without the addition of the Snyder Hope Theory-based intervention.
Behavioral: Standard Postoperative Care
Participants in the control group will receive standard postoperative care, including routine pain management, rehabilitation exercises, and general guidance on recovery after hip fracture surgery, without the addition of the Snyder Hope Theory-based intervention.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hope Levels (Herth Hope Index)
Time Frame: Pre-intervention and post-intervention (2 weeks)
The primary outcome measure is the change in the patients' hope levels, which will be assessed using the Herth Hope Index. This scale is designed to measure the psychological and emotional dimensions of hope, focusing on the patients' expectations and their outlook on recovery and life. The Herth Hope Index will be administered before and after the intervention to assess changes in hope levels.
Pre-intervention and post-intervention (2 weeks)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain Level (VAS)
Time Frame: Pre-intervention and post-intervention (2 weeks)
Pain levels will be assessed using the Visual Analog Scale (VAS), which measures the intensity of pain experienced by the patient on a scale from 0 (no pain) to 10 (worst possible pain). This measure will be used to evaluate the reduction of pain after the intervention.
Pre-intervention and post-intervention (2 weeks)
Anxiety (STAI)
Time Frame: Pre-intervention and post-intervention (2 weeks)
Anxiety levels will be assessed using the State-Trait Anxiety Inventory (STAI), a questionnaire that measures both state anxiety (temporary anxiety in a specific situation) and trait anxiety (general anxiety tendency). The tool will assess changes in anxiety after the intervention.
Pre-intervention and post-intervention (2 weeks)
Hip Joint Function (Harris Hip Score)
Time Frame: Pre-intervention and post-intervention (2 weeks)
Hip joint function will be assessed using the Harris Hip Score, which evaluates pain, function, and range of motion in the hip joint. This score helps in measuring functional recovery after hip fracture surgery.
Pre-intervention and post-intervention (2 weeks)
Quality of Life (WHOQOL-BREF)
Time Frame: Pre-intervention and post-intervention (2 weeks)
Quality of life will be measured using the WHOQOL-BREF, a brief version of the World Health Organization Quality of Life assessment. This tool evaluates physical health, psychological health, social relationships, and environment. It will assess improvements in the participants' overall quality of life post-intervention.
Pre-intervention and post-intervention (2 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Institute of Orthopaedic Surgery, Taizhou No.3 People's Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2024

Primary Completion (Estimated)

March 1, 2026

Study Completion (Estimated)

November 30, 2026

Study Registration Dates

First Submitted

February 3, 2026

First Submitted That Met QC Criteria

February 3, 2026

First Posted (Actual)

February 10, 2026

Study Record Updates

Last Update Posted (Actual)

February 10, 2026

Last Update Submitted That Met QC Criteria

February 3, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • TZSRY-HIP-HOPE-2024

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Fracture

Clinical Trials on Snyder Hope Theory-based Nursing Intervention

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Thailand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe